KPMG | Research | Pharma & Life Sciences

An overview of KPMG research in the Middle East in the Pharma & Life Sciences industry:

Middle East's life sciences players face high corruption risk A year on from the Covid-19 outbreak, bribery and corruption remain the top risk facing life sciences businesses in the Middle East.
06 April 2021

More KPMG news

KPMG report: Saudi Arabia should nurture SMEs in industrial sector As Saudi Arabia looks to diversify its oil-based economy and increase the contribution of SMEs to its national income, supporting small and mid-sized enterprises in the country will be vital.
02 February 2023
ESG due diligence on the rise in the mergers & acquisitions scene The ESG megatrend is increasingly entering the word of mergers & acquisitions, according to new research by KPMG.
26 January 2023
G42 Cloud seals partnership deal with KPMG Lower Gulf Abu Dhabi-based G42 Cloud has welcomed a consulting major to its partnership ranks, sealing a deal with KPMG’s Lower Gulf division.
24 January 2023
KPMG names Rasheed Al-Qenae as chairman of MESAC region KPMG has named Rasheed Al-Qenae, managing partner of its Kuwait organisation, as its new Chairman for the Middle East, South Asia, and Caspian (MESAC) region.
16 January 2023

1

1 found

About Consultancy-me.com

Consultancy.org network

Consultancy.org network